Krempa David sold ETON
May 22, 2026 · Form 4 insider transaction
Krempa David sold 519 shares of Eton Pharmaceuticals, Inc. at $35.00 per share, a transaction worth $18.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
519
Price
$35.00
Total value
$18.2K
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 22, 2026
Filing dateMay 27, 2026
Shares owned after25,249
OwnershipDirect
10b5-1 planNo
AmendedNo